<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18099" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Bacterial Spores</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basta</surname>
            <given-names>Marina</given-names>
          </name>
          <aff>St. George's University, School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Annamaraju</surname>
            <given-names>Pavan</given-names>
          </name>
          <aff>Loma Linda University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marina Basta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pavan Annamaraju declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18099.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Bacterial species have different coping mechanisms for selective harsh environmental conditions. One of the most common coping mechanisms is forming spores to protect themselves against ecological degrading agents. Bacterial spores are the most dormant form of bacteria since they exhibit minimal metabolism, respiration, and reduced enzyme production. Typically, Gram-positive bacteria are best known for producing intracellular spores called endospores as a survival mechanism. Endospores are highly retractile and thick-walled structures formed inside bacterial cells. It is most common for <italic toggle="yes">Bacillus</italic> species and <italic toggle="yes">Clostridium</italic> species to create endospores.<xref ref-type="bibr" rid="article-18099.r1">[1]</xref>&#x000a0;<italic toggle="yes">B. cereus</italic>&#x000a0;is a member of the&#x000a0;<italic toggle="yes">Bacillus</italic> species and is well-known for its ability to cause foodborne illness due to its spores surviving various temperatures. Similarly, <italic toggle="yes">C. perfringens</italic> spores are acid-soluble proteins that resist chemicals and heat.<xref ref-type="bibr" rid="article-18099.r2">[2]</xref></p>
        <p>Endospores can resist inactivation from ethanol treatment.<xref ref-type="bibr" rid="article-18099.r3">[3]</xref>&#x000a0;They can also survive high temperatures up to 150&#x000b0;C, making specific Gram-positive species heat resistant.&#x000a0;Further, bacterial spores can show typical viability signs at temperatures near absolute zero. Endospores are resistant to chemical agents, eg, triphenylmethane dyes, and can even protect the bacterial cells against ultraviolet radiation, extreme pH gradients, drought, and nutrition depletion. Endospores germinate back into vegetative cells (an active bacterial cell that undergoes metabolism)&#x000a0;when surrounding environmental conditions favor bacterial growth and reproduction. Several stimulants, such as optimal close-to-body temperature and diffusion of nutrients and water through bacterial cell walls by altering their surface tension, revert bacterial cells to their active vegetative cells. The process of spore formation is a multistep process. It starts from bacterial DNA replication, followed by the forespore formation, which is, by definition, the pinching of the cellular plasma membrane between the replicated chromosomes. Then, a cortex forms between the inner and outer membrane by extending the second cellular membrane to enclose the forespore with calcium and dipicolinic acid. Finally, the external spore coat surrounds the endospore before its release.<xref ref-type="bibr" rid="article-18099.r4">[4]</xref>&#x000a0;</p>
        <p>Microscopic examination to delineate the morphology of endospores involves differential staining processes such as malachite green and fluorescence staining techniques. Staining dormant bacterial samples with malachite green as the primary stain and safranine as the counteract stain results in the appearance of green oval endospores enclosed inside pink vegetative bacterial cells.<xref ref-type="bibr" rid="article-18099.r5">[5]</xref>&#x000a0;There are different locations of the endospores inside the bacterial cell. For instance, central endospores are located in the middle of the bacterial cell, while the terminal endospore appears at the end. A subterminal type of endospore appears between the cell's middle and end.<xref ref-type="bibr" rid="article-18099.r6">[6]</xref>&#x000a0;Despite their sturdy and resistant nature to environmental threats, endospores can be affected by certain eradication factors. During the 17th century, John Tyndall, a famous European physicist, discovered Tyndallization. The latter is the process of heating liquids and objects at 80 to 100&#x000b0;C for 30 minutes; then, the sample is incubated. The procedure is repeated for&#x000a0;3 consecutive days. The principle behind successive heating for&#x000a0;3 days is that heating endospores for the first time results in reverting them into vegetative cells killed through repetitive heat in the second and third days.<xref ref-type="bibr" rid="article-18099.r7">[7]</xref></p>
      </sec>
      <sec id="article-18099.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Anthrax Bioweapon (Bioterrorism)</bold>
</p>
        <p><italic toggle="yes">B. anthracis</italic> is a gram-positive spore-forming bacteria commonly found in the soil of endemic areas. It&#x000a0;is&#x000a0;1 of the most common agents used in biological warfare.&#x000a0;Many factors make&#x000a0;<italic toggle="yes">B. anthraci</italic>s a good bioweapon. Its endospores can be placed into food, water, powder, and sprays, spreading the anthrax infection without anyone's knowledge, as endospores are microscopic and cannot be tasted or felt. In 2001, anthrax spores were used as a bioweapon in the U.S. They were distributed in letters delivered by the United States Postal system, spreading anthrax infection among 22 mail handlers and customers. Anthrax bioterrorism attacks can take several other forms.&#x000a0;<italic toggle="yes">B. anthracis</italic> endospores can be released into food and water, sprayed from the air or high buildings, or even carried on clothes or shoes.&#x000a0;<italic toggle="yes">B. anthracis</italic> endospores can cast a high risk of misuse and pose severe threats to public safety and health.<xref ref-type="bibr" rid="article-18099.r8">[8]</xref></p>
        <p>
<bold><italic toggle="yes">Clostridium difficile</italic> Colitis</bold>
</p>
        <p><italic toggle="yes">C. difficile</italic> infections are associated with high morbidity, mortality, and healthcare costs. The cost of&#x000a0;<italic toggle="yes">C. difficile</italic>&#x000a0;infections is estimated at $5.4 billion in the United States - $4.7 billion (86.7%) from healthcare settings and $725 million (13.3%) incurred in the community<xref ref-type="bibr" rid="article-18099.r9">[9]</xref>. The morbidity includes an increased need for colectomies, discharges to nursing homes, and readmissions.<xref ref-type="bibr" rid="article-18099.r10">[10]</xref>&#x000a0;The morbidity and mortality rates of pseudomembranous colitis are 10%&#x000a0;to 20% in untreated elderly individuals. In patients with toxic megacolon, the mortality can be as high as 35% despite surgical intervention.<xref ref-type="bibr" rid="article-18099.r11">[11]</xref></p>
      </sec>
      <sec id="article-18099.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Anthrax:</bold>
</p>
        <p>Endospores of <italic toggle="yes">B. anthracis</italic> cause anthrax<italic toggle="yes">.</italic>&#x000a0;It has&#x000a0;4 types according to its mode of infection and the affected system:</p>
        <list list-type="order">
          <list-item>
            <p>Cutaneous anthrax</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal anthrax</p>
          </list-item>
          <list-item>
            <p>Inhalational anthrax</p>
          </list-item>
          <list-item>
            <p>Injection anthrax</p>
          </list-item>
        </list>
        <p>Cutaneous anthrax develops as a result of wound contamination with&#x000a0;<italic toggle="yes">B. anthracis&#x000a0;</italic>endospores while handling contaminated animal products. It is characterized by a painless skin ulcer with a black center and edematous blisters that may be itchy. Gastrointestinal anthrax develops as a result of the ingestion of water or food contaminated with&#x000a0;<italic toggle="yes">B. anthracis&#x000a0;</italic>endospores. The patients can present with fever, nausea, bloody vomiting, bloody diarrhea, painful swellings of the neck lymph nodes, and flushing of the face and the eyes. Inhalational anthrax results from inhaling bacterial endospores while handling contaminated animal materials, such as wool or feces. It characteristically presents with fever, shortness of breath, cough, chest discomfort, body ache, sweating, and nausea.<xref ref-type="bibr" rid="article-18099.r12">[12]</xref>. Injection anthrax develops from using syringes&#x000a0;contaminated with bacterial endospores. Clinically, it presents with the development of deep abscesses under the skin.</p>
        <p>Appropriate specimen collection is crucial to confirm the diagnosis. For inhalational anthrax, gram stain and PCR of pleural, bronchial, and CSF (if meningitis) are usually required. Skin swabs for gram stain, PCR, and skin lesion biopsy are performed in cutaneous anthrax. Similarly, gram stain, culture, and PCR of ascitic fluid, oral lesion, or rectal swab can be collected in gastrointestinal anthrax.&#x000a0;Systemic or disseminated anthrax is treated with a combination of intravenous antibiotics (ciprofloxacin, meropenem, and linezolid ) and antitoxin therapy.</p>
        <p>
<bold>Tetanus</bold>
</p>
        <p>It is a bacterial infection caused by contamination of open wounds with <italic toggle="yes">C. tetani</italic> endospores. The most common lesions owing to tetanus infection are contaminated puncture wounds, infected foot ulcers, surgical wounds, and animal bites. Within the incubation period of tetanus (7 to 10 days), the bacterial endospores produce a neurotoxin called tetanospasmin that impaired motor nerves, causing the characteristic clinical picture of tetany. The most common symptoms of tetanus are trismus (stiffness of the jaw muscles), painful body spasms, especially in the neck and abdominal muscles, triggered by a noise or physical touch, and difficulties in swallowing and fever. Tetanic contractions strengthen through the course of infection and may cause fractures and pulmonary embolism, which eventually leads to death. The diagnosis of tetanus can be through toxin assays in the blood. Tetanus has no treatment. However, prevention of tetanus is through vaccination with&#x000a0;the DTap vaccine given as a series of injections during childhood (with the first delivered at&#x000a0;2 months of age while the last vaccination is given at the age of 4). Also, for further prevention from the infection, booster doses against the toxin are given once every&#x000a0;10 years.<xref ref-type="bibr" rid="article-18099.r13">[13]</xref></p>
        <p>
<bold>Food Poisoning</bold>
</p>
        <p>Endospores causing food poisoning&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacillus <italic toggle="yes">cereus</italic></p>
          </list-item>
          <list-item>
            <p>Clostridium <italic toggle="yes">perfringes</italic></p>
          </list-item>
        </list>
        <p><italic toggle="yes">B. cereus</italic> endospores are among the leading organisms causing food poisoning. <italic toggle="yes">B. cereus</italic> food poisoning is divided into emetic and diarrheal subtypes and is caused mainly by ingesting raw and contaminated food with <italic toggle="yes">B. cereus</italic> endospores.&#x000a0;Emetic food poisoning results from <italic toggle="yes">B. cereus</italic> endospores that produce cereulide toxin, which causes nausea and vomiting. Diarrheal food poisoning results from ingesting meat products, milk, or vegetables contaminated with enterotoxin-secreting endospores. Diarrheal&#x000a0;syndrome characteristically presents with bloody or mucoid diarrhea and abdominal pain.&#x000a0;</p>
        <p><italic toggle="yes">C. perfringen</italic>s is naturally present in the intestinal microbiota. Ingestion of food contaminated with human or animal feces containing&#x000a0;<italic toggle="yes">C. perfringens</italic> endospores causes food poisoning. The symptoms usually appear 6 to 24 hours following the ingestion of contaminated food and are characterized by abdominal cramps and watery diarrhea. The diagnosis is through stool analysis and culturing&#x000a0;bacteria on differential microbiological media.&#x000a0;Diagnosis of both bacterial strains can be confirmed by isolating bacteria from feces or vomitus and culturing it on a differential media plate. Patients usually recover without the administration of antibiotics. Supportive treatment with fluid administration is the key due to excessive diarrhea and vomiting.<xref ref-type="bibr" rid="article-18099.r14">[14]</xref></p>
        <p>
<bold>Clostridial Myonecrosis</bold>
</p>
        <p>Clostridial myonecrosis (gas gangrene) is a bacterial infection caused by clostridial endospores (especially <italic toggle="yes">C. perfringens</italic>) and most commonly affects the upper and lower extremities. There are&#x000a0;2 types of gas gangrene: Traumatic and Non-traumatic syndromes. The traumatic syndrome is the most common&#x000a0;and includes&#x000a0;contamination of open wounds with <italic toggle="yes">Clostridium</italic> endospores. In contrast, the non-traumatic syndrome develops&#x000a0;diminished perfusion from&#x000a0;vascular diseases (such as atherosclerosis) or diabetes mellitus, leading to clostridial spores and&#x000a0;endotoxin-mediated gas gangrene. The common symptoms of gas gangrene are blisters with a foul smell, painful edema around the wound, air under the skin, fever, and jaundice (yellow skin and eyes) at later stages. The diagnosis involves skin culture to test for&#x000a0;<italic toggle="yes">C. perfringens</italic>. Surgical evaluation is necessary to limit the spread of gangrene. The treatment rests on prompt administration of antibiotics and surgical removal of necrotic tissues. Late-stage may require limb&#x000a0;amputation.<xref ref-type="bibr" rid="article-18099.r15">[15]</xref>&#x000a0;</p>
        <p>
<bold><italic toggle="yes">Clostridium difficile</italic> Colitis:</bold>
</p>
        <p><italic toggle="yes">C. difficile</italic> is part of the healthy intestinal microbiota. However, overgrowth of the bacteria due to prolonged intake of antibiotics (such as fluoroquinolones, clindamycin, and penicillin) disrupts the balance of colon microbiota, causing pseudomembranous colitis. This syndrome is commonly considered a nosocomial infection. <italic toggle="yes">C. difficile</italic> colitis contributes 15%&#x000a0;to 30% of&#x000a0;antibiotic-associated diarrhea. Common symptoms of this condition include fever, watery diarrhea, nausea, mucous in stool, and abdominal cramps. About 8% of&#x000a0;<italic toggle="yes">C. difficile</italic> infections develop a fulminant infection.<xref ref-type="bibr" rid="article-18099.r16">[16]</xref></p>
        <p>
<bold>Botulism</bold>
</p>
        <p><italic toggle="yes">C. botulinum</italic>&#x000a0;endospores&#x000a0;cause&#x000a0;4 significant types of botulism syndrome according to the mode of infection. Foodborne botulism is caused by contamination of food with bacterial endotoxin and spores. Wound botulism is caused by the toxin produced by colonizing&#x000a0;<italic toggle="yes">C. botulinum&#x000a0;</italic>inside open wounds. Intestinal colonization of&#x000a0;<italic toggle="yes">C. botulinum&#x000a0;</italic>in infants and adults (though rare) causes infant botulism. Inhalation botulism is caused by inhaling&#x000a0;<italic toggle="yes">C. botulinum&#x000a0;</italic>toxins.<xref ref-type="bibr" rid="article-18099.r17">[17]</xref><xref ref-type="bibr" rid="article-18099.r18">[18]</xref> Besides, there is another rare form of botulism called iatrogenic botulism that results from the injection of&#x000a0;<italic toggle="yes">C. botulinum&#x000a0;</italic>toxins, such as rarely failed botox injection procedures during cosmetic surgeries.&#x000a0;The clinical picture of all types of botulism consists of the symptoms starting from symmetrical cranial nerve paralysis, followed by descending symmetrical flaccid paralysis of voluntary muscles. Those symptoms progress to respiratory muscle paralysis, leading to respiratory failure and death. The exact dose of the lethality of botulism toxins is not accurately defined. However, the commonly estimated lethal dose of pure type A botulinum crystalline is about 0.1 micrograms for a 70-kg man.<xref ref-type="bibr" rid="article-18099.r19">[19]</xref></p>
        <p>The mortality rates attributed to botulism have improved since 1910 due to the development of intensive care techniques, such as mechanical ventilation.<xref ref-type="bibr" rid="article-18099.r20">[20]</xref>&#x000a0;Patients with suspected botulism should be&#x000a0;promptly referred to intensive care units with closer monitoring in case of progressive respiratory failure. Paralysis caused by botulinum toxin is prolonged and could last several weeks or months. Rehabilitation of paralyzed patients is crucial. The treatment of botulism is&#x000a0;antitoxin therapy, which is usually given during the first 24 hours after the onset of symptoms. Botulinum toxin can be absorbed through the mucus membranes of the eye, mouth, and nose, even though it is not transmitted through direct skin contact. Therefore, proper isolation and personal protective equipment are essential.</p>
      </sec>
      <sec id="article-18099.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Diseases associated with bacterial spores can affect different organ systems and present many symptoms. For the best patient outcomes, physicians, nurses, pharmacists, physiotherapists, and laboratory personnel must work together as an interprofessional team.</p>
      </sec>
      <sec id="article-18099.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18099&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18099">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18099/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18099">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18099.s6">
        <title>References</title>
        <ref id="article-18099.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hariram</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Labb&#x000e9;</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Spore prevalence and toxigenicity of Bacillus cereus and Bacillus thuringiensis isolates from U.S. retail spices.</article-title>
            <source>J Food Prot</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>590</fpage>
            <page-range>590-6</page-range>
            <pub-id pub-id-type="pmid">25719886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paredes-Sabja</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sarker</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Role of small, acid-soluble spore proteins in the resistance of Clostridium perfringens spores to chemicals.</article-title>
            <source>Int J Food Microbiol</source>
            <year>2008</year>
            <month>Mar</month>
            <day>20</day>
            <volume>122</volume>
            <issue>3</issue>
            <fpage>333</fpage>
            <page-range>333-5</page-range>
            <pub-id pub-id-type="pmid">18221812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palombo</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Ethanol treatment does not inactivate spore-forming bacteria - A cautionary note about the safe transport of bacteria prior to identification by MALDI-TOF MS.</article-title>
            <source>J Microbiol Methods</source>
            <year>2020</year>
            <month>May</month>
            <volume>172</volume>
            <fpage>105893</fpage>
            <pub-id pub-id-type="pmid">32184160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koser</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>McClelland</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>The Fate of Bacterial Spores in the Animal Body.</article-title>
            <source>J Med Res</source>
            <year>1917</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-68</page-range>
            <pub-id pub-id-type="pmid">19972398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Incecco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gras</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pellegrino</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A fluorescence in situ staining method for investigating spores and vegetative cells of Clostridia by confocal laser scanning microscopy and structured illuminated microscopy.</article-title>
            <source>Micron</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>110</volume>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">29689432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Andrade Cavalcante</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>De-Souza</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>de Orem</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>de Magalh&#x000e3;es</surname>
                <given-names>MIA</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Boone</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Driks</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ultrastructural analysis of spores from diverse Bacillales species isolated from Brazilian soil.</article-title>
            <source>Environ Microbiol Rep</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>155</fpage>
            <page-range>155-164</page-range>
            <pub-id pub-id-type="pmid">30421850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gould</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>History of science--spores.</article-title>
            <source>J Appl Microbiol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>507</fpage>
            <page-range>507-13</page-range>
            <pub-id pub-id-type="pmid">16907801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Anthrax: A disease of biowarfare and public health importance.</article-title>
            <source>World J Clin Cases</source>
            <year>2015</year>
            <month>Jan</month>
            <day>16</day>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-33</page-range>
            <pub-id pub-id-type="pmid">25610847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Dubberke</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Prabhu</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Browne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mast</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.</article-title>
            <source>BMC Infect Dis</source>
            <year>2016</year>
            <month>Jun</month>
            <day>18</day>
            <volume>16</volume>
            <fpage>303</fpage>
            <pub-id pub-id-type="pmid">27316794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwon</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dubberke</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>The morbidity, mortality, and costs associated with Clostridium difficile infection.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-34</page-range>
            <pub-id pub-id-type="pmid">25677706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Svaton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Skricka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kala</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Penka</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hanslianov</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grolich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Polak</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hlavsa</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment of Clostridium colitides.</article-title>
            <source>Acta Chir Iugosl</source>
            <year>2012</year>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>63</fpage>
            <page-range>63-9</page-range>
            <pub-id pub-id-type="pmid">23373360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pohanka</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bacillus anthracis as a biological warfare agent: infection, diagnosis and countermeasures.</article-title>
            <source>Bratisl Lek Listy</source>
            <year>2020</year>
            <volume>121</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-181</page-range>
            <pub-id pub-id-type="pmid">32115973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Acosta</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Leidner</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Faulkner</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19&#x000a0;years and older in the United States: A cost-effectiveness analysis.</article-title>
            <source>Prev Med</source>
            <year>2020</year>
            <month>May</month>
            <volume>134</volume>
            <fpage>106066</fpage>
            <pub-id pub-id-type="pmid">32199910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Talahmeh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abu-Rumeileh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Razem</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Development of a selective and differential media for the isolation and enumeration of Bacillus cereus from food samples.</article-title>
            <source>J Appl Microbiol</source>
            <year>2020</year>
            <month>May</month>
            <volume>128</volume>
            <issue>5</issue>
            <fpage>1440</fpage>
            <page-range>1440-1447</page-range>
            <pub-id pub-id-type="pmid">31867800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereira de Godoy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Guerreiro Godoy</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Gas gangrene, diabetes and amputations of upper extremities.</article-title>
            <source>Acta Biomed</source>
            <year>2020</year>
            <month>Mar</month>
            <day>19</day>
            <volume>91</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-46</page-range>
            <pub-id pub-id-type="pmid">32191653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kukla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Adrych</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dobrowolska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mach</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Regu&#x00142;a</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rydzewska</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for <italic>Clostridium difficile</italic> infection in adults.</article-title>
            <source>Prz Gastroenterol</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-21</page-range>
            <pub-id pub-id-type="pmid">32215122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsumura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Mechanism of intestinal absorption of botulinum neurotoxin complex].</article-title>
            <source>Nihon Saikingaku Zasshi</source>
            <year>2019</year>
            <volume>74</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-175</page-range>
            <pub-id pub-id-type="pmid">31787706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berkowitz</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Tetanus, Botulism, and Diphtheria.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5, Neuroinfectious Disease</issue>
            <fpage>1459</fpage>
            <page-range>1459-1488</page-range>
            <pub-id pub-id-type="pmid">30273248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnon</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Schechter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Inglesby</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Ascher</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Eitzen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Hauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Layton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lillibridge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Osterholm</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>O'Toole</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Perl</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Swerdlow</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tonat</surname>
                <given-names>K</given-names>
              </name>
              <collab>Working Group on Civilian Biodefense</collab>
            </person-group>
            <article-title>Botulinum toxin as a biological weapon: medical and public health management.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Feb</month>
            <day>28</day>
            <volume>285</volume>
            <issue>8</issue>
            <fpage>1059</fpage>
            <page-range>1059-70</page-range>
            <pub-id pub-id-type="pmid">11209178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18099.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gangarosa</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Donadio</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Brachman</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Dowell</surname>
                <given-names>VR</given-names>
              </name>
            </person-group>
            <article-title>Botulism in the United States, 1899-1969.</article-title>
            <source>Am J Epidemiol</source>
            <year>1971</year>
            <month>Feb</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-101</page-range>
            <pub-id pub-id-type="pmid">4925448</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
